[
    {
        "other_ids": [
            {
                "name": "Study Protocol Other Identifier",
                "value": "2015-002745-55"
            }
        ],
        "amendment_date": null,
        "keywords": [
            "Prostate Cancer"
        ],
        "dcp_id": null,
        "interventional_model": "Single Group",
        "lead_org": "Taiho Pharmaceutical Company Limited",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Male \u226518 years of age"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Histological or cytological evidence of metastatic castrate resistant prostate cancer (excluding neuroendocrine differentiation and small cell histology) who are castration resistant and have:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Dose escalation: documented progression defined in PCWG3 and/or intolerance to abiraterone and/or enzalutamide therapy, as well as 1 or more chemotherapies."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Expansion: I. Group A: documented progression after abiraterone or enzalutamide and chemotherapy consisting of no more than 2 prior taxane-based therapies ii. Group B: documented progression after only abiraterone or enzalutamide therapy without any chemotherapy iii. Measurable disease per RECIST 1.1 and/or bone metastases"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "ECOG performance status of \u22641 on Day 1 Cycle 1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "Ongoing androgen deprivation with serum testosterone <50 ng/dL"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "Expansion Phase only: willingness to undergo baseline core biopsies, if feasible"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "Ability to take medication orally"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Adequate organ function"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Agree to use effective contraception during the study and for 30 days after the last dose of TAS3681"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "Willing to comply with scheduled visits and procedures"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 11,
                    "description": "QTcF \u2265 450 ms, history of QTc prolongation or predisposition for QTc prolongation or family history of sudden cardiac death or QT prolongation"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 12,
                    "description": "History or presence of heart failure or left ventricular dysfunction with ejection fraction <40% within the previous 6 months; if >6 months cardiac function within normal limits and free of cardiac-related symptoms"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 13,
                    "description": "History or presence of atrial fibrillation, atrial flutter, or paroxysmal supraventricular tachycardia; the presence or history of ventricular arrhythmias including ventricular fibrillation and ventricular tachycardia"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 14,
                    "description": "Presence of cardiac pacemaker or implantable cardioverter-defibrillator"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 15,
                    "description": "History or presence of bradycardia or conduction abnormalities"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 16,
                    "description": "History or presence of cardiac arrest or unexplained syncope"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 17,
                    "description": "Hypokalemia"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 18,
                    "description": "History of myocardial infarction or severe unstable angina"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 19,
                    "description": "Any medication administered within 2 weeks prior to 1st dose of TAS3681 that is known to prolong the QT interval or be arrhythmogenic"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "Received G-CSF, radiotherapy for extended field, anticancer chemotherapy, investigational agents, or major surgery within 4 weeks of study drug administration; receipt of anticoagulant or CYP3A inhibitor within 2 weeks of study drug administration"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "Serious illness or medical condition that could affect the safety or tolerability of study treatments"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "Received prior treatment with TAS3681"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 23,
                    "description": "User of herbal products"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 24,
                    "description": "Any condition or reason that in the opinion of the investigator, interferes with the ability of the participant to participate in the trial"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 25,
                    "description": "To be eligible to participate in the food effect assessment (Escalation Phase only), participants must not have a history or presence of any clinically significant abnormality involving the gastrointestinal tract and an inability to fast for a minimum of 8 hours"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "MALE",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "This is a first in human, multinational, Phase 1, open-label study of TAS3681 evaluating\r\n      safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity\r\n      in patients with metastatic castration-resistant prostate cancer (mCRPC) for which there is\r\n      no standard therapy. Eligible participants will be enrolled to evaluate safety and determine\r\n      the MTD/recommended dose for TAS3681, including a preliminary evaluation of food effect and\r\n      antitumor activity. The study will be conducted in 2 parts, Dose Escalation (Enrollment\r\n      closed) and Expansion (Enrollment open), and will enroll up to approximately 200 patients.",
        "official_title": "A Phase 1, Open-Label, Non-Randomized, Safety, Tolerability and Pharmacokinetic Study of TAS3681 in Patients With Metastatic Castration Resistant Prostate Cancer",
        "_phase_sort_order": 4,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Baseline, end of week 4, at the end of every 12 weeks, and end of every 12 weeks through study completion, an average of 6 months",
                "name": "Change from baseline in Circulating Tumor Cell (CTC) number in blood",
                "description": null,
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "Through Day 15 in Cycle 1 (each cycle is 28 days)",
                "name": "Escalation Phase: Accumulation ratio of TAS3681",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Through Day 15 in Cycle 1 (each cycle is 28 days)",
                "name": "Escalation Phase: Area under the concentration-time curve of TAS3681",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Through Day 15 in Cycle 1 (each cycle is 28 days)",
                "name": "Escalation Phase: Maximum concentration of TAS3681 in plasma",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Through 6 months (or until patient discontinuation)",
                "name": "Escalation Phase: Number of patients with treatment-emergent adverse events and significant ECG abnormalities",
                "description": "Based on treatment-emergent adverse events, serious adverse events (SAEs), clinical laboratory tests, vital signs, 12-lead electrocardiograms (ECGs)",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Up to 6 months (or until patient discontinuation)",
                "name": "Escalation Phase: Prostate Specific Antigen (PSA) response",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Through Day 15 in Cycle 1 (each cycle is 28 days)",
                "name": "Escalation Phase: Terminal half-life time of TAS3681",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 6 months (or until patient discontinuation)",
                "name": "Escalation Phase: Time to PSA progression",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "At Day 15 in Cycle 1 (each cycle is 28 days)",
                "name": "Escalation Phase: Time to reach maximum concentration of TAS3681",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Through 6 months ( or until patient discontinuation)",
                "name": "Escalation Phase: Tumor response per PCWG3/RECIST 1.1 including ORR, and duration of response (DOR)",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Through Day 15 during Cycle 1 (each cycle is 28 days)",
                "name": "Expansion Phase: Area under the concentration-time curve of TAS3681",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Through Day 15 during Cycle 1 (each cycle is 28 days)",
                "name": "Expansion Phase: Maximum concentration of TAS3681 in plasma",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Through 6 months (or until patient discontinuation)",
                "name": "Expansion Phase: Number of patients with treatment-emergent adverse events and significant ECG abnormalities",
                "description": "Based on treatment-emergent adverse events, serious adverse events (SAEs), clinical laboratory tests, vital signs, 12-lead ECGs",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Through 6 months (or until patient discontinuation)",
                "name": "Expansion Phase: Overall Response Rate (ORR)",
                "description": "ORR based on investigator-assessed radiographic response per PCWG3/modified RECIST 1.1",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Up to 6 months (or until patient discontinuation)",
                "name": "Expansion Phase: Prostate Specific Antigen (PSA) response",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Through Day 15 of Cycle 1 (each cycle is 28 days)",
                "name": "Expansion Phase: Terminal half-life time of TAS3681",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Through Day 15 during Cycle 1 (each cycle is 28 days)",
                "name": "Expansion Phase: Time to reach maximum concentration of TAS3681",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Through 6 months (or until patient discontinuation)",
                "name": "Expansion:Tumor response measures including duration of response (DOR), radiologic progression-free survival (rPFS), overall survival (OS), clinical benefit rate (CBR; percentage of participants with complete response, partial response or stable disease)",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline",
                "name": "Number of patients with AR-v7 positivity in circulating tumor cells",
                "description": null,
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "Through 1 month",
                "name": "Number of patients with dose-limiting toxicities",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Through 6 months (or until patient discontinuation)",
                "name": "Severity and impact of pain on daily function using Brief Pain Inventory - Short Form (BPI-SF).",
                "description": null,
                "type_code": "OTHER_PRE_SPECIFIED"
            }
        ],
        "phase": "I",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 1,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT02566772",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Lab Value",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C129259",
                "name": "Castration Levels of Testosterone",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C77140",
                    "C157377"
                ],
                "parents": [
                    "C157377"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C157377",
                "name": "Testosterone Level Finding",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C77140"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "Testosterone Less than 50 Nanograms per Deciliter",
                    "Testosterone Less than 50 Nanograms/Deciliter"
                ],
                "nci_thesaurus_concept_id": "C157378",
                "name": "Testosterone Less than 50 ng/dL",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C157377",
                    "C77140",
                    "C3367",
                    "C36292"
                ],
                "parents": [
                    "C157377"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2022-05-03",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "CRPC",
                    "Castration-Resistant Prostate Carcinoma",
                    "Metastatic Castration-Resistant Prostate Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C130234",
                "name": "Castration-Resistant Prostate Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C167255",
                    "C8946"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Prostate Carcinoma AJCC v8",
                    "Stage IV Prostate Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140173",
                "name": "Stage IV Prostate Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140163"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prostate Cancer Metastatic",
                    "Prostate Carcinoma Metastatic",
                    "Metastatic Prostate Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C8946",
                "name": "Metastatic Prostate Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4863",
                    "C146893"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Refractory Cancer",
                    "resistant cancer",
                    "clinical resistance"
                ],
                "nci_thesaurus_concept_id": "C120186",
                "name": "Refractory Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C7628"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Prostate Tumor",
                    "Tumor of the Prostate",
                    "Neoplasm of the Prostate",
                    "Neoplasm of Prostate",
                    "Tumor of Prostate"
                ],
                "nci_thesaurus_concept_id": "C3343",
                "name": "Prostate Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3054",
                    "C26865"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Refractory Tumor"
                ],
                "nci_thesaurus_concept_id": "C7628",
                "name": "Refractory Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm",
                    "Neoplasms, NOS",
                    "tumor",
                    "Neoplastic Growth",
                    "Tumor, NOS",
                    "Neoplasia",
                    "Neoplasm, NOS",
                    "Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C181196",
                "name": "Male Reproductive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C164141",
                    "C8561"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C150534",
                "name": "Refractory Malignant Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8561",
                    "C120186"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C4968"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Tumor, malignant, NOS",
                    "Malignancy",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease",
                    "Malignant Growth",
                    "CA",
                    "Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Prostate Disease"
                ],
                "nci_thesaurus_concept_id": "C26865",
                "name": "Prostate Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27019"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Neoplasm of the Prostate",
                    "Malignant Tumor of the Prostate",
                    "Malignant Neoplasm of Prostate",
                    "Malignant Prostate Tumor",
                    "Malignant Tumor of Prostate"
                ],
                "nci_thesaurus_concept_id": "C7378",
                "name": "Malignant Prostate Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3343",
                    "C8561"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor, metastatic",
                    "Metastatic Tumor",
                    "Neoplasm, metastatic",
                    "Metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Genitourinary System Malignant Neoplasm",
                    "Metastatic Malignant Genitourinary System Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C157774",
                "name": "Metastatic Genitourinary Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C177149",
                "name": "Refractory Male Reproductive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C181196",
                    "C150534",
                    "C8511"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Urogenital Disease",
                    "Genitourinary Disorder"
                ],
                "nci_thesaurus_concept_id": "C156660",
                "name": "Genitourinary System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm of the Reproductive System",
                    "Reproductive Neoplasm",
                    "Reproductive System Tumor",
                    "Neoplasm of Reproductive System",
                    "Reproductive Tumor",
                    "Tumor of Reproductive System",
                    "Tumor of the Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C3674",
                "name": "Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4875",
                    "C156482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C8511",
                "name": "Refractory Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C120186"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C36310"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Genitourinary System Cancer",
                    "Genitourinary Cancer",
                    "Malignant Genitourinary Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C156484",
                "name": "Malignant Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C156482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36076",
                "name": "Malignant Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C3674"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Cancer",
                    "Secondary Malignancy"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36255",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C164141",
                "name": "Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C156484"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Tumor",
                    "Tumor, secondary",
                    "Neoplasm, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Tumor of the Male Reproductive System",
                    "Malignant Neoplasm of Male Reproductive System",
                    "Malignant Tumor of Male Reproductive System",
                    "Male reproductive system cancer, NOS",
                    "Malignant Male Reproductive System Tumor",
                    "Male reprod. system cancer, NOS",
                    "Malignant Neoplasm of the Male Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C8561",
                "name": "Malignant Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3054",
                    "C36076"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Male Reproductive System Disease",
                    "Disorder of Male Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C27019",
                "name": "Male Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4875"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Epithelial Neoplasm",
                    "Epithelial tumor, malignant",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Malignant Epithelioma",
                    "Epithelioma Malignant",
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Epithelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9305",
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Cancer of the Prostate",
                    "Other Prostate Carcinoma",
                    "Carcinoma of Prostate",
                    "Carcinoma of the Prostate",
                    "Prostate cancer, NOS",
                    "Cancer of Prostate",
                    "Prostate Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C4863",
                "name": "Prostate Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C181196",
                    "C7378"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor_Morphology",
                    "Tumor Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C167255",
                "name": "Refractory Prostate Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4863",
                    "C177149"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Urogenital Carcinoma",
                    "Metastatic Genitourinary Cancer",
                    "Metastatic Genitourinary Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C146893",
                "name": "Metastatic Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C164141",
                    "C3482",
                    "C157774"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor of the Male Reproductive System",
                    "Male Reproductive System Tumor",
                    "Tumor of Male Reproductive System",
                    "Neoplasm of Male Reproductive System",
                    "Neoplasm of the Male Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C3054",
                "name": "Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27019",
                    "C3674"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Diseases",
                    "Disease",
                    "Diseases and Disorders",
                    "disease_term",
                    "Diagnosis",
                    "Disease or Disorder, Non-Neoplastic",
                    "disease type",
                    "Disorders",
                    "Disease or Disorder",
                    "Disorder",
                    "condition",
                    "disease_type"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Genital Disorders",
                    "Reproductive System Disease",
                    "Disorder of Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C4875",
                "name": "Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156482",
                "name": "Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor Stage (Pathologic)",
                    "Prostate Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C140163",
                "name": "Prostate Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4863"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "TO-TAS3681-101",
        "active_sites_count": 1,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hormone Therapy Agent",
                            "Hormonal Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C147908",
                        "name": "Hormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Research"
                        ],
                        "nci_thesaurus_concept_id": "C15429",
                        "name": "Research Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C16203"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C43431",
                        "name": "Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C63536",
                        "name": "Study",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C15429"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Molecularly Targeted Therapy Agent",
                            "Targeted Therapeutic Agent",
                            "Targeted Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Lab Test",
                            "Tests",
                            "Laboratory Test",
                            "Test",
                            "Lab Tests"
                        ],
                        "nci_thesaurus_concept_id": "C25294",
                        "name": "Laboratory Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hormone Antagonist",
                            "Antihormone Agents"
                        ],
                        "nci_thesaurus_concept_id": "C547",
                        "name": "Antihormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C74957",
                        "name": "Mixed Category Laboratory Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25294"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C64263",
                        "name": "Laboratory Biomarker Analysis",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C74957",
                            "C63333"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C63333",
                        "name": "Biomarker Analysis",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C62674",
                        "name": "Pharmacological Study",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C63536"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmaceutical Agent",
                            "Drug Substance",
                            "Pharmaceuticals",
                            "Pharmacological Substance",
                            "Agent",
                            "Drug",
                            "Pharmacologic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C16203",
                        "name": "Clinical or Research Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C43431"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Androgen Receptor Antagonist",
                            "AR Antagonist",
                            "AR Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C146993",
                        "name": "Androgen Receptor Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C242",
                            "C163758"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Intervention Strategies",
                            "Intervention",
                            "Procedure"
                        ],
                        "nci_thesaurus_concept_id": "C25218",
                        "name": "Intervention or Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C16203"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Anti-Cancer Agents",
                            "Antiproliferative Drugs",
                            "Anti-Tumor Agents",
                            "Antineoplastic Drugs",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Cancer Drug"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Androgen Antagonists",
                            "Antiandrogens",
                            "Anti-Androgen",
                            "Anti-Androgen Agents",
                            "Antiandrogen Agents"
                        ],
                        "nci_thesaurus_concept_id": "C242",
                        "name": "Antiandrogen Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C547"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C137818",
                        "name": "Androgen Receptor Antagonist TAS3681",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C146993"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "TAS3681",
                "description": "All participants will receive TAS3681 in 28-day cycles. The Escalation phase includes participants who have progressed after abiraterone, enzalutamide and chemotherapy. Eleven dose escalation cohorts are planned, one of which includes a preliminary assessment of food effect. The MTD/recommended dose for further development will be used for participants in the Expansion Phase. The Expansion Phase will enroll participants who have progressed after abiraterone or enzalutamide with chemotherapy consisting of no more than 2 prior taxane-based therapies (Group A) or without any chemotherapy (Group B). Participants receive TAS3681 until discontinuation criteria are met.",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2017-01254",
        "why_study_stopped": null,
        "brief_summary": "The purpose of this trial is to investigate the safety and tolerability of TAS3681, to find\r\n      the maximum tolerated dose (MTD)/recommended dose of TAS3681 (Escalation Phase) and to\r\n      further evaluate safety and preliminary efficacy of TAS3681 at the MTD/recommended dose\r\n      (Expansion Phase).",
        "brief_title": "Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer",
        "status_history": [
            {
                "status_date": "2022-05-03T00:00:00.000001",
                "status": "CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2016-03-01T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 200,
        "prior_therapy": [],
        "_current_trial_status_sort_order": 7,
        "start_date": "2016-03-01",
        "record_verification_date": "2023-02-01",
        "ctep_id": null,
        "current_trial_status": "Closed to Accrual",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "NA"
        },
        "acronym": null,
        "nci_programs": [],
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Prostate"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2023-10-01",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]